Back to News
Market Impact: 0.3
111, Inc. Posts Q2'26 Results As Asset-Light Shifts Lowers Revenue But Improved Efficiency; Stock Up
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany FundamentalsM&A & Restructuring
111, Inc. reported unaudited Q2 2026 results with revenue declining sharply versus the prior-year quarter. The decline reflects the China healthcare platform's ongoing strategic transition away from an asset-heavy operating model, creating near-term pressure on reported growth.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
YI-0.70
More News
- 111 Inc. receives going-private proposal at $4.52 per ADS
- California AG Says Paramount-WBD Merger Would Hurt the State
- Pokémon card curbs send shares of Japanese online marketplace Mercari on a bumpy ride
- US to Sell F-35s to Saudi Arabia in $24.3 Billion Deal
- California AG Bonta on Paramount-Warner Bros., Meta and AI
- Jensen Huang says Nvidia will sell twice as many chips next year